Steffen Dietz

928 total citations
20 papers, 621 citations indexed

About

Steffen Dietz is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Steffen Dietz has authored 20 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Steffen Dietz's work include Cancer Genomics and Diagnostics (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Genetic factors in colorectal cancer (3 papers). Steffen Dietz is often cited by papers focused on Cancer Genomics and Diagnostics (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Genetic factors in colorectal cancer (3 papers). Steffen Dietz collaborates with scholars based in Germany, Brazil and Cuba. Steffen Dietz's co-authors include Holger Sültmann, Albrecht Stenzinger, Volker Endris, Anna‐Lena Volckmar, Anja Lisa Riediger, Peter Schirmacher, Michael Thomas, Thoas Fioretos, Michael Meister and Basetti Madhu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Steffen Dietz

20 papers receiving 615 citations

Peers

Countries citing papers authored by Steffen Dietz

Since Specialization

Citations

This map shows the geographic impact of Steffen Dietz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Dietz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Dietz more than expected).

Fields of papers citing papers by Steffen Dietz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Dietz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Dietz. The network helps show where Steffen Dietz may publish in the future.

Co-authorship network of co-authors of Steffen Dietz

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Dietz. A scholar is included among the top collaborators of Steffen Dietz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Dietz. Steffen Dietz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis 2021 ·npj Precision Oncology ·(unknown), Petros Christopoulos, Zhao Yuan, (unknown), (unknown), (unknown), Martin Reck, Matthias Schlesner, Michael Meister, Marc A. Schneider, Steffen Dietz, Albrecht Stenzinger, Michael Thomas, Holger Sültmann	23
2	Expression of Biofilm-Degrading Enzymes in Plants and Automated High-Throughput Activity Screening Using Experimental Bacillus subtilis Biofilms 2021 ·Frontiers in Bioengineering and Biotechnology ·Patrick Opdensteinen, Steffen Dietz, (unknown), Johannes F. Buyel	8
3	Earlier extracranial progression and shorter survival in ALK- rearranged lung cancer with positive liquid rebiopsies 2021 ·Translational Lung Cancer Research ·Petros Christopoulos, Steffen Dietz, (unknown), (unknown), Daniel Kazdal, Anna‐Lena Volckmar, (unknown), Volker Endris, Michael Meister, Mark Kriegsmann, (unknown), Martin Reck, Albrecht Stenzinger, Michael Thomas, Holger Sültmann	16
4	A Cerberus‐Inspired Anti‐Infective Multicomponent Gatekeeper Hydrogel against Infections with the Emerging “Superbug” Yeast Candida auris 2020 ·Macromolecular Bioscience ·Dennis Kubiczek, (unknown), (unknown), Steffen Dietz, Ann‐Kathrin Kissmann, (unknown), (unknown), Andreas Wittgens, (unknown), (unknown), Octávio Luiz Franco, (unknown), Anselmo J. Otero‐González, Paul Walther, Kay E. Gottschalk, Tanja Weil, Frank Rosenau	18
5	Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages 2020 ·Cancers ·(unknown), Farastuk Bozorgmehr, Sabine Wrenger, Steffen Dietz, Claus Peter Heußel, Gudula Heußel, (unknown), (unknown), Manuel Feißt, Michael Thomas, Heiko Golpon, Andreas Günther, Holger Sültmann, Thomas Muley, Sabina Janciauskiene, Michael Meister, Marc A. Schneider	3
6	Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1–ALK-rearranged lung cancer 2019 ·Molecular Case Studies ·Steffen Dietz, Petros Christopoulos, Lisa Gu, Anna‐Lena Volckmar, Volker Endris, Zhao Yuan, (unknown), Tomasz Żemojtel, Claus Peter Heußel, Marc A. Schneider, Michael Meister, Thomas Muley, Martin Reck, Matthias Schlesner, Michael Thomas, Albrecht Stenzinger, Holger Sültmann	17
7	Circulating MicroRNAs as Potential Biomarkers for Lung Cancer 2019 ·Recent results in cancer research ·Sabrina Müller, (unknown), Steffen Dietz, Holger Sültmann	24
8	Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 with Improved Antifungal Activity 2019 ·ACS Omega ·(unknown), (unknown), (unknown), (unknown), Hilda Garay, (unknown), (unknown), José A. C. Delgado, Daniel G. Rivera, Glay Chinea, Rosemeire Cristina Linhari Rodrigues Pietro, Steffen Stenger, Barbara Spellerberg, Dennis Kubiczek, (unknown), Steffen Dietz, Frank Rosenau, Márcio W. Paixão, Ludger Ständker, Anselmo J. Otero‐González	31
9	Defining molecular risk in ALK+ NSCLC 2019 ·Oncotarget ·Petros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger Sültmann, Michael Thomas, Albrecht Stenzinger	29
10	Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival 2019 ·Cancers ·Petros Christopoulos, Steffen Dietz, Martina Kirchner, Anna‐Lena Volckmar, Volker Endris, Olaf Neumann, (unknown), Claus Peter Heußel, Felix Herth, Martin Eichhorn, Michael Meister, Jan Budczies, Michael Allgäuer, Jonas Leichsenring, Tomasz Żemojtel, Helge Bischoff, Peter Schirmacher, Michael Thomas, Holger Sültmann, Albrecht Stenzinger	31
11	Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas 2018 ·International Journal of Cancer ·Steffen Dietz, Aviezer Lifshitz, Daniel Kazdal, Alexander Harms, Volker Endris, H. Winter, Albrecht Stenzinger, Arne Warth, Martin Sill, Amos Tanay, Holger Sültmann	24
12	Digital PCR After MALDI–Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma 2018 ·PROTEOMICS - CLINICAL APPLICATIONS ·Daniel Kazdal, Rémi Longuespée, Steffen Dietz, Rita Casadonte, Kristina Schwamborn, Anna‐Lena Volckmar, Jörg Kriegsmann, Katharina Kriegsmann, Margaux Fresnais, Albrecht Stenzinger, Holger Sültmann, Arne Warth, Mark Kriegsmann	18
13	A field guide for cancer diagnostics using cell‐free DNA: From principles to practice and clinical applications 2017 ·Genes Chromosomes and Cancer ·Anna‐Lena Volckmar, Holger Sültmann, Anja Lisa Riediger, Thoas Fioretos, Peter Schirmacher, Volker Endris, Albrecht Stenzinger, Steffen Dietz	146
14	Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas 2017 ·International Journal of Cancer ·Steffen Dietz, Alexander Harms, Volker Endris, Florian Eichhorn, Mark Kriegsmann, Rémi Longuespée, Albrecht Stenzinger, Holger Sültmann, Arne Warth, Daniel Kazdal	20
15	Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy 2017 ·Oncotarget ·Steffen Dietz, Holger Sültmann, Yuejun Du, Eva Reisinger, Anja Lisa Riediger, Anna‐Lena Volckmar, Albrecht Stenzinger, Matthias Schlesner, Dirk Jäger, Markus Hohenfellner, Stefan Duensing, Carsten Grüllich, Sascha Pahernik	10
16	Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients 2016 ·PLoS ONE ·Steffen Dietz, Uwe Schirmer, Clémentine Mercé, Nikolas von Bubnoff, Edgar Dahl, Michael Meister, Thomas Muley, Michael Thomas, Holger Sültmann	37
17	Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients 2016 ·Scientific Reports ·Anja Lisa Riediger, Steffen Dietz, Uwe Schirmer, Michael Meister, (unknown), Marc A. Schneider, Thomas Muley, Michael Thomas, Holger Sültmann	42
18	Analysis of the Binding Moiety Mediating the Interaction between Monocarboxylate Transporters and Carbonic Anhydrase II 2015 ·Journal of Biological Chemistry ·(unknown), Steffen Dietz, (unknown), Christopher D. Boone, Robert McKenna, Joachim W. Deitmer, Holger M. Becker	29
19	Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin 2012 ·British Journal of Cancer ·Sara Piccirillo, Steffen Dietz, Basetti Madhu, John R. Griffiths, Stephen J. Price, V. Peter Collins, Colin Watts	89
20	Implication de récepteurs P2X et P2U dans l’effet constricteur de l’ATP sur le lit vasculaire pancréatique 1999 ·Journal de la Société de Biologie ·Dominique Hillaire‐Buys, Steffen Dietz, J Chapal, Patrice X. Petit, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact